Apollo Hospitals EnterpriseBOM:508869 +0.94%92 EBITDA Margin % is 16.12% as of Mar. 2026, which is 25% above its 10-year median of 12.87. GuruFocus rates BOM:508869 with a GF Score™ of 92/100 and a GF Value™ of ₹8,723.27 (Fairly Valued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks better than 63.81% on this metric.
Apollo Hospitals Enterprise (BOM:508869) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Apollo Hospitals Enterprise EBITDA Margin % Related Terms
Apollo Hospitals Enterprise EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:508869 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise (BOM:508869) has a EBITDA Margin % of 16.12% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Apollo Hospitals Enterprise and its competitors. This is 25% above median its historical median of 12.87. Over the past decade, Apollo Hospitals Enterprise's EBITDA Margin % has ranged from 9.60 to 17.26. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #241 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 36.2%.
Is Apollo Hospitals Enterprise's EBITDA Margin % too high?
Apollo Hospitals Enterprise's current EBITDA Margin % of 16.12% is 25% above median its 10-year median of 12.87. Over the past 10 years, this metric has ranged from a low of 9.60 to a high of 17.26. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Apollo Hospitals Enterprise's value of 16.12% is 57.9% above this industry median. Based on the distribution chart, Apollo Hospitals Enterprise ranks #241 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apollo Hospitals Enterprise has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #241 out of 666 companies for EBITDA Margin %. This puts Apollo Hospitals Enterprise in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Apollo Hospitals Enterprise's value of 16.12% is 57.9% above this benchmark. Historically, Apollo Hospitals Enterprise's own EBITDA Margin % has ranged from 9.60 to 17.26 over the past decade. While the company's 10-year median is 12.87 vs. the industry median of 10.21, Apollo Hospitals Enterprise has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current EBITDA Margin % of 16.12% is 57.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current EBITDA Margin % is 16.12%, which is 25% above median its own 10-year median of 12.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,723.27, compared to a current price of ₹8,697.55 — trading 0.3% below its estimated fair value. The current EBITDA Margin % is 16.12%, which is 25% above median its 10-year median of 12.87 and 57.9% above the Healthcare Providers & Services industry median of 10.21. Apollo Hospitals Enterprise's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current EBITDA Margin % is 16.12% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued.
The current stock price of ₹8,697.55 is trading 0.3% below its estimated GF Value™ of ₹8,723.27.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
EBITDA Margin %: 16.12% (25% above median its 10-year median of 12.87)
GF Value™: ₹8,723.27 vs. price of ₹8,697.55 (0.3% below fair value)
Industry Position: 57.9% above the Healthcare Providers & Services median (#241 of 666)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
92GF Score
Get the complete analysis for BOM:508869
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
